In StartupBlink's Corporate Startup Activity Index, Boehringer Ingelheim ranks #86 globally and #7 in Germany. It ranks #9 in the Healthtech industry and #8 in the Pharmaceuticals subindustry.
Boehringer Ingelheim has supported 59 startups through programs and investments, with those companies raising a combined $4 billion over the last ten years. The company currently operates 2 active startup programs.
Boehringer Ingelheim has deployed more than $424 million in startup investments through Boehringer Ingelheim Venture Fund and partnership programs, strengthening its position as one of the leading innovation-driven corporations globally.
The company currently runs 2 active startup programs supporting 59 startups worldwide across industries such as Ecommerce & Retail, Hardware & IoT, Healthtech, and Software & Data. Its venture arm Boehringer Ingelheim Venture Fund has invested in over 56 startups since it was founded in 2010.
The corporate-innovation activity is concentrated in Healthtech, Software & Data, and Ecommerce & Retail, categories where Boehringer Ingelheim's scale provides outsized leverage to early-stage startups.
Sector, HQ-city and program-location breakdowns for the startups associated with Boehringer Ingelheim. Unlock the full breakdown with StartupBlink Pro.
Boehringer Ingelheim engages startups through 2 active programs, supporting 59 startups in total based on our database.

Boehringer Ingelheim's top 5 associated startups have raised 47% of the $4 billion raised in the last ten years across all 59 associated startups, led by Click Therapeutics at $929 million. Boehringer Ingelheim is associated with 54 active startups and 5 exits. Boehringer Ingelheim Venture Fund supports the largest number of startups, with 56 associated startups.
Disclaimer: This is based on general open web search and prone to mistakes.
| Startup | SB Score | Industry | HQ city | Link Type to Corporation | Linked via |
|---|---|---|---|---|---|
| SB 545 | Healthtech | Austin | Direct Investment | Boehringer Ingelheim — Corporate Self | |
| SB 475 | Healthtech | New York | Direct Investment | Boehringer Ingelheim — Corporate Self | |
Wellth | SB 435 | Software & Data | Los Angeles | Program Investment | Boehringer Ingelheim Venture Fund |
Take ownership to keep this page accurate. Partner with StartupBlink to showcase your innovation activity to 1M+ startup ecosystem stakeholders.